U.S. Markets closed

CytomX Therapeutics: 3Q Earnings Snapshot

SOUTH SAN FRANCISCO, Calif. (AP) _ CytomX Therapeutics Inc. (CTMX) on Thursday reported a loss of $23.7 million in its third quarter.

On a per-share basis, the South San Francisco, California-based company said it had a loss of 52 cents.

The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 39 cents per share.

The biopharmaceutical company posted revenue of $10.7 million in the period, which also fell short of Street forecasts. Three analysts surveyed by Zacks expected $23.6 million.

CytomX Therapeutics shares have decreased 59% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $6.15, a decrease of 61% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CTMX at https://www.zacks.com/ap/CTMX